Search research articles
Contact Us
Filters
Showing results (81-90 of 128) with videos related to
Page
of 13
Sort By:
The New England Journal of Medicine
|
November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
Jia Ruan, Peter Martin, Bijal Shah, et al.
AIDS Research and Human Retroviruses
|
January 13, 2010
One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India
Amita Gupta, Dattaray G Saple, Girish Nadkarni, et al.
The Lancet. Haematology
|
December 5, 2024
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
Ibrahim Aldoss, Gail J Roboz, Renato Bassan, et al.
The Journal of Clinical Investigation
|
November 13, 2013
A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
Tint Lwin, Xiaohong Zhao, Fengdong Cheng, et al.
Human Pathology
|
March 23, 2023
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review
Ling Zhang, Bijal Shah, Yumeng Zhang, et al.
The American Journal of Cardiology
|
June 19, 2019
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy
Michael G Fradley, Matthew Gliksman, Josephine Emole, et al.
Heart (British Cardiac Society)
|
July 2, 2021
Association between ibrutinib treatment and hypertension
Dae Hyun Lee, Fahad Hawk, Kieun Seok, et al.
Advances in Therapy
|
March 18, 2024
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor
Gilles Salles, Jenny M H Chen, Ina Zhang, et al.
Scientific Reports
|
May 14, 2016
Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke
Michael J Van Kanegan, Denise E Dunn, Linda S Kaltenbach, et al.
Blood Advances
|
September 2, 2022
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma
Jeremy S Abramson, Elizabeth Bengston, Robert Redd, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 128) with videos related to
Sort By:
Page
of 13
The New England Journal of Medicine
|
November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
Jia Ruan, Peter Martin, Bijal Shah, et al.
AIDS Research and Human Retroviruses
|
January 13, 2010
One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India
Amita Gupta, Dattaray G Saple, Girish Nadkarni, et al.
The Lancet. Haematology
|
December 5, 2024
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
Ibrahim Aldoss, Gail J Roboz, Renato Bassan, et al.
The Journal of Clinical Investigation
|
November 13, 2013
A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
Tint Lwin, Xiaohong Zhao, Fengdong Cheng, et al.
Human Pathology
|
March 23, 2023
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review
Ling Zhang, Bijal Shah, Yumeng Zhang, et al.
The American Journal of Cardiology
|
June 19, 2019
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy
Michael G Fradley, Matthew Gliksman, Josephine Emole, et al.
Heart (British Cardiac Society)
|
July 2, 2021
Association between ibrutinib treatment and hypertension
Dae Hyun Lee, Fahad Hawk, Kieun Seok, et al.
Advances in Therapy
|
March 18, 2024
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor
Gilles Salles, Jenny M H Chen, Ina Zhang, et al.
Scientific Reports
|
May 14, 2016
Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke
Michael J Van Kanegan, Denise E Dunn, Linda S Kaltenbach, et al.
Blood Advances
|
September 2, 2022
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma
Jeremy S Abramson, Elizabeth Bengston, Robert Redd, et al.
Page
of 13